Video is available - Log in to view. You must be registered to the event to view content
• Discuss the impact of novel myosin inhibitors in the context of previous management approaches such as myomectomy and conventional medications in the treatment of Hypertrophic obstructive cardiomyopathy • Identify the key role of echocardiography in detection of hypertrophic obstructive cardiomyopathy as well as the complementary roles of MRI and stress testing to determine the extent of disease.
| Dr. Igal A. Sebag, Canada | Dr. Amer Johri, Canada |
Dr. Theodore Abraham, Canada
ASE Lecture: Emerging Novel Therapies and the Role of Multimodality Imaging in Hypertrophic Cardiomyopathy